United States - English - NLM (National Library of Medicine)

fosun pharma usa inc - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol maleate sterile ophthalmic gel forming solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate ophthalmic gel forming solution is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease [see warnings, obstructive pulmonary disease ]; (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure [see warnings, cardiac failure ]; (7) cardiogenic shock; or (8) hypersensitivity to any component of this product. instructions for use timolol maleate (tim oh lol mal ee ate) ophthalmic gel forming solution, 0.25% and 0.5% read this instructions for use that comes with timolol maleate ophthalmic gel forming solution before you start using it and each time you get a refill. there may be new information. this information does not take the place of talking w

United States - English - NLM (National Library of Medicine)

dr. reddy's laboratories, inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol maleate ophthalmic gel forming solution is indicated in the treatment of elevatedintraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate ophthalmic gel forming solution is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease [see warnings,obstructive pulmonary disease ]; (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure[see warnings, cardiac failure ]; (7) cardiogenic shock; or (8) hypersensitivity to any component of this product. timolol maleate ophthalmic gel forming solution 0.25% and 0.5% read this instructions for use that comes with timolol maleate ophthalmic gel forming solution before you start using it and each time you get a refill.there may be new information. this information does not take the place of talking with your doctor about your medical condition or treatment. important information about timolol maleate o

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol maleate ophthalmic gel forming solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate ophthalmic gel forming solution is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease [see warnings, obstructive pulmonary disease ]; (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure [see warnings, cardiac failure ]; (7) cardiogenic shock; or (8) hypersensitivity to any component of this product. timolol maleate (tim’ oh lol mal’ ee ate) ophthalmic gel forming solution, 0.5% read this instructions for use that comes with timolol maleate ophthalmic gel forming solution before you start using it and each time you get a refill. there may be new information. this information does not take the place of talking with your doctor about your medical condition or treatment. important informat

United States - English - NLM (National Library of Medicine)

lifestar pharma llc - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate ophthalmic solution is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease [see warnings]; (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure [see warnings]; (7) cardiogenic shock; or (8) hypersensitivity to any component of this product. timolol maleate ophthalmic solution, usp 0.25% and 0.5% (tim oh lol mal ee ate) read this instructions for use that comes with timolol maleate ophthalmic solution before you start using it and each time you get a refill. there may be new information. this information does not take the place of talking with your doctor about your medical condition or treatment. important information about timolol maleate ophthalmic solution: - use timolol maleate ophthalmic solution ex

Canada - English - Health Canada

micro labs limited - timolol (timolol maleate); dorzolamide (dorzolamide hydrochloride) - solution - 5mg; 20mg - timolol (timolol maleate) 5mg; dorzolamide (dorzolamide hydrochloride) 20mg

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - latanoprost,timolol maleate -

Canada - English - Health Canada

aa pharma inc - timolol maleate - tablet - 5mg - timolol maleate 5mg - beta-adrenergic blocking agents

Canada - English - Health Canada

aa pharma inc - timolol maleate - tablet - 10mg - timolol maleate 10mg - beta-adrenergic blocking agents

Canada - English - Health Canada

aa pharma inc - timolol maleate - tablet - 20mg - timolol maleate 20mg - beta-adrenergic blocking agents

New Zealand - English - Medsafe (Medicines Safety Authority)

rex medical ltd - timolol maleate 0.3417%{relative} - eye drops, solution - 0.25 % - active: timolol maleate 0.3417%{relative} excipient: benzalkonium chloride dibasic sodium phosphate dihydrate disodium edetate monobasic sodium phosphate dihydrate polyvinyl alcohol povidone sodium chloride sodium hydroxide water - timolol eye drops are indicated for the reduction of elevated intraocular pressure. in clinical trials it has been shown to reduce intraocular pressure in patients with ocular hypertension, chronic open-angle glaucoma, aphakic glaucoma, some forms of secondary glaucoma, and narrow angles and a history of spontaneous or iatrogenically induced narrow-angle closure in the opposite eye in whom reduction of intraocular pressure is necessary.